Monopar Therapeutics MNPR
NASDAQ MNPR
$74.23 +2.76 (+3.86%)
At close: Oct 20, 2026 · 4:00 PM EDT

Monopar Therapeutics (MNPR) Operating Leases (2022 - 2026)

Updated

Monopar Therapeutics' Operating Leases was $107,829 in Q2 2026, up 34.2% from $80,366 a year earlier.

Analysis

Monopar Therapeutics (MNPR) Operating Leases (2022 - 2026) Analysis & Trends

At the end of FY2025, Operating Leases at Monopar Therapeutics came in at $154,920.

  • Operating Leases shows a three-year compound annual growth rate of 164.1% (FY2022 to FY2025).
  • In earlier years, Operating Leases was $8,408 in FY2022.
  • Quarterly Operating Leases has moved between $8,408 (Q4 2022) and $154,920 (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Monopar Therapeutics 635.73 Mn 353.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 107,829.00
Dec 31, 2025 154,920.00
Sep 30, 2025 70,881.00
Jun 30, 2025 80,366.00
Dec 31, 2022 8,408.00
Sep 30, 2022 20,850.00
Jun 30, 2022 33,092.00
Mar 31, 2022 25,338.00
API Access

Monopar Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=MNPR&period=max&api_key=YOUR_API_KEY